{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T22:38:17Z","timestamp":1782859097962,"version":"3.54.5"},"reference-count":50,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T00:00:00Z","timestamp":1757980800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010425","name":"Tri-Service General Hospital","doi-asserted-by":"publisher","award":["TSGH_C04_113043"],"award-info":[{"award-number":["TSGH_C04_113043"]}],"id":[{"id":"10.13039\/501100010425","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010425","name":"Tri-Service General Hospital","doi-asserted-by":"publisher","award":["TSGH_C02_114034"],"award-info":[{"award-number":["TSGH_C02_114034"]}],"id":[{"id":"10.13039\/501100010425","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 113-2314-B-016-039"],"award-info":[{"award-number":["NSTC 113-2314-B-016-039"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022871","name":"National Defense Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001869","name":"Academia Sinica","doi-asserted-by":"publisher","award":["VTA113-T-3-1"],"award-info":[{"award-number":["VTA113-T-3-1"]}],"id":[{"id":"10.13039\/501100001869","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011913","name":"Kaohsiung Veterans General Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011913","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["110-2314-B-016-002-MY3"],"award-info":[{"award-number":["110-2314-B-016-002-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.isci.2025.113594","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:21:57Z","timestamp":1758615717000},"page":"113594","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Identification of IL18\/IL18R1 signaling as a predictive biomarker of SGLT2 inhibitor efficacy in type 2 diabetes"],"prefix":"10.1016","volume":"28","author":[{"given":"I-Jou","family":"Teng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Hsing","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Chen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Chiang","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chieh-Hua","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng-Fei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Luen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Ju","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Hsun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin-Ya","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3513-2487","authenticated-orcid":false,"given":"Feng-Chih","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2025.113594_bib1","article-title":"SGLT2 inhibitors: Beyond glycemic control","volume":"35","author":"Hasan","year":"2024","journal-title":"J. Clin. Transl. Endocrinol."},{"key":"10.1016\/j.isci.2025.113594_bib2","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.isci.2025.113594_bib3","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.isci.2025.113594_bib4","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa1812389","article-title":"Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes","volume":"380","author":"Wiviott","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.isci.2025.113594_bib5","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","article-title":"Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy","volume":"380","author":"Perkovic","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.isci.2025.113594_bib6","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in Patients with Chronic Kidney Disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.isci.2025.113594_bib7","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.isci.2025.113594_bib8","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","article-title":"KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease","volume":"105","year":"2024","journal-title":"Kidney Int."},{"key":"10.1016\/j.isci.2025.113594_bib9","doi-asserted-by":"crossref","first-page":"S158","DOI":"10.2337\/dc24-S009","article-title":"9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2024","volume":"47","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/j.isci.2025.113594_bib10","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","article-title":"2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"44","author":"McDonagh","year":"2023","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.isci.2025.113594_bib11","series-title":"IDF DIABETES ATLAS","author":"Magliano","year":"2021"},{"key":"10.1016\/j.isci.2025.113594_bib12","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","article-title":"Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.isci.2025.113594_bib13","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3803\/EnM.2024.2142","article-title":"Discrepancies in Dapagliflozin Response in Terms of Glycemic Control and Body Weight Reduction","volume":"40","author":"Jun","year":"2025","journal-title":"Endocrinol. Metab."},{"key":"10.1016\/j.isci.2025.113594_bib14","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s13300-022-01276-2","article-title":"Review of SGLT2i for the Treatment of Renal Complications: Experience in Patients with and Without T2D","volume":"13","author":"Gonzalez-Albarran","year":"2022","journal-title":"Diabetes Ther."},{"key":"10.1016\/j.isci.2025.113594_bib15","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1161\/CIRCULATIONAHA.123.065251","article-title":"Cardiorenal Biomarkers, Canagliflozin, and Outcomes in Diabetic Kidney Disease: The CREDENCE Trial","volume":"148","author":"Januzzi","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.isci.2025.113594_bib16","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.2337\/dc22-1157","article-title":"Dapagliflozin Improves the Urinary Proteomic Kidney-Risk Classifier CKD273 in Type 2 Diabetes with Albuminuria: A Randomized Clinical Trial","volume":"45","author":"Curovic","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.isci.2025.113594_bib17","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1210\/clinem\/dgab086","article-title":"Effect of Dapagliflozin on Urine Metabolome in Patients with Type 2 Diabetes","volume":"106","author":"Bletsa","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.isci.2025.113594_bib18","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.1093\/eurheartj\/ehac495","article-title":"Effect of empagliflozin on circulating proteomics in heart failure: mechanistic insights into the EMPEROR programme","volume":"43","author":"Zannad","year":"2022","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.isci.2025.113594_bib19","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1021\/acs.jproteome.2c00544","article-title":"Plasma Olink Proteomics Identifies CCL20 as a Novel Predictive and Diagnostic Inflammatory Marker for Preeclampsia","volume":"21","author":"Wang","year":"2022","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.isci.2025.113594_bib20","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1038\/s41422-021-00562-1","article-title":"Distinct immune signatures discriminate between asymptomatic and presymptomatic SARS-CoV-2(pos) subjects","volume":"31","author":"Yu","year":"2021","journal-title":"Cell Res."},{"key":"10.1016\/j.isci.2025.113594_bib21","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/dom.12670","article-title":"Efficacy and safety of sodium-glucose co-transporter-2 inhibitors in type 2 diabetes mellitus: systematic review and network meta-analysis","volume":"18","author":"Zaccardi","year":"2016","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.isci.2025.113594_bib22","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1007\/s13300-021-01104-z","article-title":"SGLT2 Inhibitors and the Clinical Implications of Associated Weight Loss in Type 2 Diabetes: A Narrative Review","volume":"12","author":"Janez","year":"2021","journal-title":"Diabetes Ther."},{"key":"10.1016\/j.isci.2025.113594_bib23","doi-asserted-by":"crossref","DOI":"10.1093\/ckj\/sfae237","article-title":"Sodium glucose co-transporter 2 inhibitors in the treatment of glomerular diseases: a CKJ controversy","volume":"17","author":"Caravaca-Fontan","year":"2024","journal-title":"Clin. Kidney J."},{"key":"10.1016\/j.isci.2025.113594_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0279889","article-title":"Effect of SGLT-2 inhibitors on body composition in patients with type 2 diabetes mellitus: A meta-analysis of randomized controlled trials","volume":"17","author":"Pan","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2025.113594_bib25","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/s41581-024-00836-y","article-title":"Applications of SGLT2 inhibitors beyond glycaemic control","volume":"20","author":"O'Hara","year":"2024","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.isci.2025.113594_bib26","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1475-2840-9-11","article-title":"The role of interleukin-18 in the metabolic syndrome","volume":"9","author":"Tr\u00f8seid","year":"2010","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.isci.2025.113594_bib27","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/iid3.170","article-title":"Increased adipose tissue expression of IL-18R and its ligand IL-18 associates with inflammation and insulin resistance in obesity","volume":"5","author":"Ahmad","year":"2017","journal-title":"Immun. Inflamm. Dis."},{"key":"10.1016\/j.isci.2025.113594_bib28","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.isci.2025.113594_bib29","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00125-022-05815-1","article-title":"Ketones: the double-edged sword of SGLT2 inhibitors?","volume":"66","author":"Lupsa","year":"2023","journal-title":"Diabetologia"},{"key":"10.1016\/j.isci.2025.113594_bib30","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.cmet.2023.03.014","article-title":"Metformin triggers a kidney GDF15-dependent area postrema axis to regulate food intake and body weight","volume":"35","author":"Zhang","year":"2023","journal-title":"Cell Metab."},{"key":"10.1016\/j.isci.2025.113594_bib31","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cmet.2018.12.016","article-title":"GDF15 Provides an Endocrine Signal of Nutritional Stress in Mice and Humans","volume":"29","author":"Patel","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.isci.2025.113594_bib32","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1172\/JCI93025","article-title":"CD163+ macrophages promote angiogenesis and vascular permeability accompanied by inflammation in atherosclerosis","volume":"128","author":"Guo","year":"2018","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.isci.2025.113594_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174715","article-title":"Dapagliflozin exerts anti-inflammatory effects via inhibition of LPS-induced TLR-4 overexpression and NF-kappaB activation in human endothelial cells and differentiated macrophages","volume":"918","author":"Abdollahi","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.isci.2025.113594_bib34","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.redox.2018.11.004","article-title":"Selenium-binding protein 1 (SELENBP1) is a marker of mature adipocytes","volume":"20","author":"Steinbrenner","year":"2019","journal-title":"Redox Biol."},{"key":"10.1016\/j.isci.2025.113594_bib35","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.77457","article-title":"HIF-1alpha induces glycolytic reprograming in tissue-resident alveolar macrophages to promote cell survival during acute lung injury","volume":"11","author":"Woods","year":"2022","journal-title":"eLife"},{"key":"10.1016\/j.isci.2025.113594_bib36","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.peptides.2015.06.009","article-title":"Vasoactive intestinal peptide (VIP) differentially affects inflammatory immune responses in human monocytes infected with viable Salmonella or stimulated with LPS","volume":"71","author":"Askar","year":"2015","journal-title":"Peptides"},{"key":"10.1016\/j.isci.2025.113594_bib37","doi-asserted-by":"crossref","first-page":"4659","DOI":"10.4049\/jimmunol.1601458","article-title":"CCR2 Regulates the Immune Response by Modulating the Interconversion and Function of Effector and Regulatory T Cells","volume":"198","author":"Bakos","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.isci.2025.113594_bib38","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.164009","article-title":"EGR2 is an epigenomic regulator of phagocytosis and antifungal immunity in alveolar macrophages","volume":"9","author":"Kolostyak","year":"2024","journal-title":"JCI Insight"},{"key":"10.1016\/j.isci.2025.113594_bib39","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.molimm.2018.05.007","article-title":"Genome-wide analysis reveals TNFAIP8L2 as an immune checkpoint regulator of inflammation and metabolism","volume":"99","author":"Li","year":"2018","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.isci.2025.113594_bib40","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.immuni.2024.02.001","article-title":"Interleukin-2 signaling in the regulation of T cell biology in autoimmunity and cancer","volume":"57","author":"Shouse","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.isci.2025.113594_bib41","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1161\/CIRCULATIONAHA.116.020838","article-title":"Oxidized Phospholipids on Lipoprotein(a) Elicit Arterial Wall Inflammation and an Inflammatory Monocyte Response in Humans","volume":"134","author":"van der Valk","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.isci.2025.113594_bib42","doi-asserted-by":"crossref","first-page":"W1","DOI":"10.7326\/M18-1377","article-title":"PROBAST: A Tool to Assess Risk of Bias and Applicability of Prediction Model Studies: Explanation and Elaboration","volume":"170","author":"Moons","year":"2019","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.isci.2025.113594_bib43","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s13098-023-01087-w","article-title":"Gender-specific impacts of thigh skinfold thickness and grip strength for predicting osteoporosis in type 2 diabetes","volume":"15","author":"Lu","year":"2023","journal-title":"Diabetol. Metab. Syndr."},{"key":"10.1016\/j.isci.2025.113594_bib44","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2337\/diacare.27.6.1487","article-title":"Use and abuse of HOMA modeling","volume":"27","author":"Wallace","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.isci.2025.113594_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2021.100168","article-title":"Proximity Extension Assay in Combination with Next-Generation Sequencing for High-throughput Proteome-wide Analysis","volume":"20","author":"Wik","year":"2021","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.isci.2025.113594_bib46","series-title":"R: A Language and Environment for Statistical Computing","year":"2013"},{"key":"10.1016\/j.isci.2025.113594_bib47","series-title":"ggplot2 : Elegant Graphics for Data Analysis","author":"Wickham","year":"2016"},{"key":"10.1016\/j.isci.2025.113594_bib48","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1093\/bioinformatics\/btz931","article-title":"ShinyGO: a graphical gene-set enrichment tool for animals and plants","volume":"36","author":"Ge","year":"2020","journal-title":"Bioinformatics"},{"key":"10.1016\/j.isci.2025.113594_bib49","doi-asserted-by":"crossref","DOI":"10.2202\/1557-4679.1065","article-title":"The Benjamini-Hochberg method in the case of discrete test statistics","volume":"3","author":"Ferreira","year":"2007","journal-title":"Int. J. Biostat."},{"key":"10.1016\/j.isci.2025.113594_bib50","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/bioinformatics\/btt703","article-title":"Causal analysis approaches in Ingenuity Pathway Analysis","volume":"30","author":"Kramer","year":"2014","journal-title":"Bioinformatics"}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004225018553?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004225018553?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T03:26:37Z","timestamp":1778901997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004225018553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":50,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S2589004225018553"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2025.113594","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of IL18\/IL18R1 signaling as a predictive biomarker of SGLT2 inhibitor efficacy in type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2025.113594","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"113594"}}